Nachrichten/Radius Health, Menarini Group Says Phase 3 Trial of Breast Cancer…Radius Health, Menarini Group Says Phase 3 Trial of Breast Cancer Drug Candidate Elacestrant Meets Primary Endpoint20. Mai 202209:05 UTC